Induction of a reversible, non‐cytotoxic S‐phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection

作者: Ru Zhou , Masayuki Fukui , Hye Joung Choi , Bao Ting Zhu

DOI: 10.1111/J.1476-5381.2009.00268.X

关键词:

摘要: Background and purpose:  Resveratrol (RES) has been shown to prolong lifespan prevent cancer formation. At present, the precise cellular mechanisms of RES actions are still not clearly understood, this is focus study. Experimental approach:  Using human hepatocellular carcinoma-derived HepG2 cells as a model, we studied RES-induced changes in cell growth, cycle progression apoptosis. Key results:  at lower concentrations induced strong but reversible S-phase delay mild DNA synthesis inhibition, yet without causing apoptotic or necrotic death. high concentrations, apoptosis, which mainly mediated by mitochondrial pathway. Overall, was relatively weak agent. Mechanistically, MEK inhibition identified an important early signalling event for apoptosis. In comparison, activation CDK2 checkpoint kinase 2, phosphatidylinositol 3′-kinase/Akt pathway contributed induction reversible, non-cytotoxic delay. Conclusion implications:  It hypothesized that may represent useful mechanistic strategy prolongation prevention. When cycles selectively slowed down S phase, it would cumulatively increase total organism if numbers divisions given assumed remain basically constant. Likewise, when proceed through reduced pace during replication, allow more time repair damaged DNA, thereby reduce chances mutagenesis tumour initiation.

参考文章(46)
Jacob Falck, Niels Mailand, Randi G. Syljuåsen, Jiri Bartek, Jiri Lukas, The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature. ,vol. 410, pp. 842- 847 ,(2001) , 10.1038/35071124
Michael B. Kastan, Jiri Bartek, Cell-cycle checkpoints and cancer Nature. ,vol. 432, pp. 316- 323 ,(2004) , 10.1038/NATURE03097
Jared R. Mayers, Benjamin W. Iliff, Steven J. Swoap, Resveratrol treatment in mice does not elicit the bradycardia and hypothermia associated with calorie restriction The FASEB Journal. ,vol. 23, pp. 1032- 1040 ,(2009) , 10.1096/FJ.08-115923
Gary K. Schwartz, Manish A. Shah, Targeting the Cell Cycle: A New Approach to Cancer Therapy Journal of Clinical Oncology. ,vol. 23, pp. 9408- 9421 ,(2005) , 10.1200/JCO.2005.01.5594
Matt Kaeberlein, Brian K. Kennedy, Does resveratrol activate yeast Sir2 in vivo Aging Cell. ,vol. 6, pp. 415- 416 ,(2007) , 10.1111/J.1474-9726.2007.00314.X
Philipp Kaldis, Eiman Aleem, Cell cycle sibling rivalry: Cdc2 vs. Cdk2. Cell Cycle. ,vol. 4, pp. 1491- 1494 ,(2005) , 10.4161/CC.4.11.2124
Richard A. Woo, Randy Y.C. Poon, Cyclin-dependent kinases and S phase control in mammalian cells. Cell Cycle. ,vol. 2, pp. 316- 324 ,(2003) , 10.4161/CC.2.4.468
Anthony C. Faber, Fay J. Dufort, Derek Blair, Dean Wagner, Mary F. Roberts, Thomas C. Chiles, Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas. Biochemical Pharmacology. ,vol. 72, pp. 1246- 1256 ,(2006) , 10.1016/J.BCP.2006.08.009
Margie T. Borra, Brian C. Smith, John M. Denu, Mechanism of Human SIRT1 Activation by Resveratrol Journal of Biological Chemistry. ,vol. 280, pp. 17187- 17195 ,(2005) , 10.1074/JBC.M501250200
Hai-Bo Zhou, Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice World Journal of Gastroenterology. ,vol. 11, pp. 280- 284 ,(2005) , 10.3748/WJG.V11.I2.280